| Literature DB >> 30327676 |
Larisa M Gearhart-Serna1,2,3, Nishad Jayasundara3,4, Moises Tacam5, Richard Di Giulio3, Gayathri R Devi1,2,6.
Abstract
Polycyclic aromatic hydrocarbon (PAH) exposure is widespread, and many PAHs are considered carcinogenic. The PAH-contaminated AWI Superfund site in Virginia provides a model for studying a complex PAH mixture and its extrapolation to cancer risk and PAH exposure in the general population. We examined cancer risk at the Superfund site due to sediment-derived PAHs and then evaluated PAH sources in the general population and potentially vulnerable subpopulations upon PAH mixture exposure. The PAH mixture was assessed for potential carcinogenicity using the US EPA's OncoLogic™ ranking tool and the US EPA list of priority PAHs. Cancer risk due to PAH exposure was calculated for Superfund site users and compared to the US EPA assessment. Human intake and health endpoints of PAHs within the mixture were extracted from USEtox® chemical fate database, while mean intake exposure was calculated for U.S. adults for select PAHs using NHANES database urinary biomarkers. Eleven PAH compounds within the mixture were of carcinogenic concern, and seven PAHs conveyed significant excess cancer risk at the Superfund site and in the general population, wherein PAH-contaminated seafood ingestion was a main contributor. Other dietary sources of PAHs derived from PAH-contaminated soil or water could also play a role in total exposure. Vulnerable populations to PAH exposure and coinciding increased cancer risk may include, in addition to smokers, children and non-Hispanic blacks, which is a public health concern.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30327676 PMCID: PMC6169233 DOI: 10.1155/2018/5610462
Source DB: PubMed Journal: J Environ Public Health ISSN: 1687-9805
Monte Carlo simulation variables and distributions for cancer risk assessment due to oral and dermal sediment exposure at the AWI Superfund site.
| Parameter | Symbol | Units | Distribution-AT | Distribution-CT | Distribution-AR | Distribution-CR |
|---|---|---|---|---|---|---|
| Concentration of 7 PAHs in sediment | CS | mg/kg | 0.283 | 0.283 | 0.283 | 0.283 |
| Average time-Cancer | AT | days | 25550 | 25550 | 25550 | 25550 |
| Age-dependent adjustment factor | ADAF | Unitless | 1 | 10 | 1 | 10 |
| Conversion factor | CF | Unitless | 0.000001 | 0.000001 | 0.000001 | 0.000001 |
| Body weight | BW | kg | 80 ± 20 | 15 ± 3.75 | 80 ± 20 | 15 ± 3.75 |
|
| ||||||
|
| ||||||
| Benzo(a)anthracene cancer slope factor | BaA | mg/kg-day | 7.30 | 7.30 | 7.30 | 7.30 |
| Benzo(a)pyrene cancer slope factor | BaP | mg/kg-day | 7.30 | 7.30 | 7.30 | 7.30 |
| Benzo(b)fluoranthene cancer slope factor | BbF | mg/kg-day | 7.30 | 7.30 | 7.30 | 7.30 |
| Benzo(k)fluoranthene cancer slope factor | BkF | mg/kg-day | 7.30 | 7.30 | 7.30 | 7.30 |
| Chrysene cancer slope factor | Chr | mg/kg-day | 7.30 | 7.30 | 7.30 | 7.30 |
| Dibenz(a,h)anthracene cancer slope factor | Dib | mg/kg-day | 7.30 | 7.30 | 7.30 | 7.30 |
| Indeno(1,2,3-c,d)pyrene cancer slope factor | Ind | mg/kg-day | 7.30 | 7.30 | 7.30 | 7.30 |
| Exposure frequency | EF | days/year | 40 ± 10 | 52 ± 13 | 32 ± 8 | 48 ± 12 |
| Exposure duration | ED | years | 20 ± 5 | 6 ± 1.5 | 20 ± 5 | 6 ± 1.5 |
| Ingestion rate-sediment | IR-S | mg/day | 20 ± 5 | 50 ± 12.5 | 20 ± 5 | 50 ± 12.5 |
|
| ||||||
|
| ||||||
| Benzo(a)anthracene cancer slope factor | BaA | mg/kg-day | 2.50 | 2.50 | 2.50 | 2.50 |
| Benzo(a)pyrene cancer slope factor | BaP | mg/kg-day | 2.50 | 2.50 | 2.50 | 2.50 |
| Benzo(b)fluoranthene cancer slope factor | BbF | mg/kg-day | 2.50 | 2.50 | 2.50 | 2.50 |
| Benzo(k)fluoranthene cancer slope factor | BkF | mg/kg-day | 2.50 | 2.50 | 2.50 | 2.50 |
| Chrysene cancer slope factor | Chr | mg/kg-day | 2.50 | 2.50 | 2.50 | 2.50 |
| Dibenz(a,h)anthracene cancer slope factor | Dib | mg/kg-day | 2.50 | 2.50 | 2.50 | 2.50 |
| Indeno(1,2,3-c,d)pyrene cancer slope factor | Ind | mg/kg-day | 2.50 | 2.50 | 2.50 | 2.50 |
| Exposure frequency | EF | days/year | 40 ± 10 | 52 ± 13 | 32 ± 8 | 48 ± 12 |
| Exposure duration | ED | years | 20 ± 5 | 6 ± 1.5 | 20 ± 5 | 6 ± 1.5 |
| Soil to skin adherence factor | AF | mg/cm2-day | 0.07 ± 0.0175 | 0.2 ± 0.05 | 0.2 ± 0.05 | 0.07 ± 0.0175 |
| Dermal absorption fraction | ABSd | Unitless | 0.13 | 0.13 | 0.13 | 0.13 |
| Skin surface area available for contact | SA | cm2 | 6032 ± 1508 | 2373 ± 593.25 | 6032 ± 1508 | 2373 ± 593.25 |
AT = adult trespasser; CT = child trespasser; AR = adult recreational user; CR = child recreational user.
Cancer-relevant polycyclic aromatic hydrocarbons are present in Superfund sediment, as determined by US EPA priority PAHs list and OncoLogic™ carcinogenicity ranking tool.
| Concentration | Standard deviation (ng/mL) | US EPA priority PAH | OncoLogic™ carcinogenic concern level | |
|---|---|---|---|---|
| Naphthalene | 1617.2 | 341.2 | + | |
| Phenanthrene | 597.1 | 171.7 | + | Low |
| Fluoranthene | 422.6 | 35.7 | + | |
| Acenaphthene | 404.7 | 96.4 | + | Low |
| Fluorene | 321.2 | 188.5 | + | |
| Pyrene | 288.0 | 21.4 | + | Low |
| Carbazole | 246.0 | 60.1 | ||
| Dibenzofuran | 207.7 | 82.9 | ||
| 1-Methylnaphthalene | 161.5 | 31.7 | ||
| Benz(a)anthracene | 77.6 | 7.8 | + | Low-moderate |
| Anthracene | 73.1 | 12.1 | + | |
| Benzo(b)fluoranthene | 66.1 | 4.8 | + | Moderate-high |
| Dibenzothiophene | 63.4 | 49.8 | ||
| Chrysene | 62.0 | 4.7 | + | |
| 1,2-Benzofluorene | 46.5 | 4.1 | ||
| 2,6-Dimethylnaphthalene | 44.7 | 39.4 | ||
| Benzo(a)pyrene | 44.3 | 2.4 | + | High |
| Retene | 43.8 | 3.6 | ||
| 2-Methylphenanthrene | 39.8 | 10.7 | ||
| Benzo(e)pyrene | 31.2 | 7.3 | ||
| Benzo(k)fluoranthene | 26.6 | 1.7 | + | Low-moderate |
| 1-Methylphenanthrene | 20.5 | 3.1 | ||
| Acenaphthylene | 17.0 | 8.5 | + | |
| Benzo(g,h,i)perylene | 14.7 | 1.3 | + | |
| Picene | 14.2 | 1.2 | Moderate | |
| 3,4-Benzofluorene | 9.0 | 3.0 | ||
| Perylene | 8.8 | 0.8 | Low | |
| Benzo(a)fluoranthene | 6.9 | 0.7 | Low-moderate | |
| Dibenz(a,l)pyrene | 6.2 | 0.5 | High | |
| Indeno(1,2,3-c,d)pyrene | 3.6 | 0.5 | + | Moderate |
| Benzo(b)chrysene | 3.5 | 0.4 | ||
| Dibenz(a,j)anthracene | 2.8 | 0.6 | Moderate | |
| Dibenz(a,h)anthracene | 2.8 | 0.6 | + | High |
| Benzo(c)phenanthrene | 2.4 | 0.3 | Low-moderate | |
| 3-Methylcholanthrene | 0.0 | 0.0 |
Concentrations determined by mass spectrometry in previous study [22].
Figure 1Indirect PAH exposure drives sediment-based cancer risk at the Superfund site. (a) Schematic calculation design of the original Superfund site cancer risk assessment due to sediment exposure, whereas our assessment does not take into account indirect oral exposure. Also includes the seven PAH contaminants of concern in sediment utilized for the cancer risk assessment, both AWI and our assessment. (b) Total cancer risk calculated in the original AWI risk assessment at the Superfund site due to sediment exposure, with the percentage of that cancer risk due to PAH or other contaminant exposure. Cancer risk due to Superfund site sediment exposure as calculated in the original AWI Superfund site risk assessment (c) and as calculated in our direct exposure assessment (d) in this experiment.
Figure 2Monte Carlo simulation of cancer risk at the AWI Superfund site. Histograms of cancer risk distribution due to (a) oral exposure and (b) dermal exposure to seven PAH COCs in AWI Superfund site sediment by adult trespassers, child trespassers, adult recreational users, and child recreational users. (c) Descriptive statistics table of cancer risk distributions from Monte Carlo Simulation. COC = contaminant of concern.
Figure 3PAH mixture exposure varies in the human population depending on source: (a) chemical fate modeling of PAHs in the environment from emission source to environmental compartment to human intake route, as utilized in the USEtox model; (b) USEtox database distribution of human intake of a mixture of 7 PAH COCs. Human intake is measured by inhalation, drinking water, produce, meat and dairy, or fish, depending on the environmental compartment into which the PAH is emitted; (c) cancer cases and (d) daily adjusted life year (DALY) per kg emitted into different environmental compartments for a PAH mixture containing the seven Superfund site sediment contaminants of concern.
Figure 4Intake exposure modeling of select PAHs for U.S. adults. Mean intake exposure (μg/kg-day) calculated for (a) all 2003–2008 NHANES participants and stratified by (b) smoking status, (c) gender, or (d) race/ethnicity.